Back to results
US 12,359,239 B2Granted
Relative potency assay for viral vector encoding isomerohydrolases
AssigneeSpark Therapeutics, Inc.
InventorLinda Couto
Life of this patent
Estimating the term…
Abstract
Methods for assaying function and/or activity and/or potency of isomerohydrolase proteins are provided.
Claims50
A method for measuring isomerohydrolase activity, wherein the method is linear from about 1×104 to about 2×106 AAV vector genomes per cell, comprising:
- (a) contacting cells expressing Lecithin Retinol Acyltransferase (LRAT) with an adeno-associated viral (AAV) vector genomes comprising a transgene encoding an isomerohydrolase protein under conditions allowing cell transduction;
- (b) incubating transduced cells under conditions allowing expression of the encoded isomerohydrolase protein;
- (c) collecting and lysing the transduced cells to produce an extract comprising the encoded isomerohydrolase protein;
- (d) incubating said extract with a substrate for a period of time and under conditions allowing conversion of the substrate by the isomerohydrolase protein to a 11-cis-retinol reaction product;
- (e) subjecting said 11-cis-retinol reaction product to column chromatography thereby producing a column chromatography purified 11-cis-retinol reaction product;
- and
- (f) subjecting said column chromatography purified 11-cis-retinol reaction product to mass spectrometry thereby quantifying the 11-cis-retinol reaction product, wherein the amount of the reaction product reflects isomerohydrolase activity thereby measuring isomerohydrolase activity, wherein the method is linear from about 1×104 to about 2×106 AAV vector genomes per cell.
4 more elements
Dependencies are inferred from the claim text.